OTCM
CBNT
Market cap238kUSD
Nov 03, Last price
0.00USD
Name
C-Bond Systems Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
C-Bond Systems, Inc., a nanotechnology enterprise founded in 2013 and based in Houston, Texas, concentrates on the ownership, development, production, and sale of its proprietary C-Bond technology across the United States. The company's innovative product line, rooted in C-Bond technology, includes: C-Bond NanoShield: A patented nanotechnology system designed to bolster windshield safety and performance through glass strengthening and the application of hydrophobic properties. C-Bond Secure: This patented, non-toxic, water-based nanotechnology solution enhances the durability of architectural glass and improves the functional characteristics of window film-to-glass integrations. C-Bond BRS: A patented nanotechnology ballistic-resistant film system that substantially increases the structural integrity of glass. Beyond its core C-Bond offerings, the company also distributes MB-10 and Vimoba disinfectant tablets. These products are supplied to a broad spectrum of clients and markets, encompassing educational institutions (schools and buses), automotive dealerships, global distribution networks, a variety of service providers, and sectors such as transportation detailing, automotive, trucking, RVs, rental agencies, service vehicles, mass transit, golf carts, aviation, trains, and marine operations.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||